Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical artemether gel for seborrheic keratosis
ISRCTN12424904Phase 2Completed
- Sponsor
- EpiPharm AG
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of artemether in seborrheic keratosis (SK) (2 arms), sponsored by EpiPharm AG. Primary endpoints: Regression of lesions by Investigator Global Assessment and Reduction in lesion size. Started Feb 2015; status: completed.
02
Drugs
artemether
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on ISRCTN12424904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12424904.